Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 


PS: The quotes after 2017-05-10 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Bristol-Myers Squ Static Chart

Rise of
+0.56 (+0.90%) Bristol-Myers Squ - [Ticker: BMY]Chart Bristol-Myers Squ  News Bristol-Myers Squ  Download Historical Prices for Metastock Bristol-Myers Squ and Others  Technical Analysis Bristol-Myers Squ  
Last Trade62.22Last Trade Time2017-11-01 - 19:35:00
Variation+0.56 (+0.90%)Open61.86
High62.31Low61.49
Volume3,541,547Average Volume (3m)0
YieldBid / Ask62.21 x 900 - 62.22 x 1,400
Former Close61.6652 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Bristol-Myers Squ [BMY]:   (ordered by relevance)
Bristol Myers (BMY) Posts Data From Multiple Myeloma Study  Yahoo FinanceView Full coverage on Google News Is There An Opportunity With Bristol-Myers Squibb Company's (NYSE:BMY) 48% Undervaluation?  Yahoo Movies UK What?s Next For Bristol Myers Squibb Stock?  Forbes Bristol Myers Squibb (BMY) Q2 2022 Earnings Call Transcript  The Motley Fool Bristol Myers Squibb - Bristol Myers Squibb Announces Extension of Turning Point Tender Offer  Bristol-Myers Squibb What To Expect From Bristol Myers Squibb Stock After Q2 Results?  Forbes Earning 10% Income On Bristol Myers Squibb With Options (NYSE:BMY)  Seeking Alpha Qube Research & Technologies Ltd Purchases Shares of 48492 Bristol-Myers Squibb (NYSE:BMY)  Defense World June 2024 Options Now Available For Bristol Myers Squibb (BMY)  Nasdaq Bristol Myers Squibb Teams Up with Jack and Jill of America Inc. to Expand Tomorrow's Innovators Program to Increase Black Representation in the Healthcare Industry  PharmiWeb.com Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights  Business Wire Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag (nivolumab and relatlimab) for Treatment of Patients with Unresectable or Metastatic Melanoma  Yahoo Finance Bristol Myers discloses $39 mln in Russia exit costs  Reuters Earnings Preview: Bristol Myers Squibb (BMY) Q2 Earnings Expected to Decline  Nasdaq Bristol-Myers Squibb (BMY) Reports CheckMate -914 Trial Evaluating Opdivo Plus Yervoy Did Not Meet Endpoint  StreetInsider.com Bristol Myers Squibb Co. stock outperforms competitors on strong trading day  MarketWatch Midyear stock changes show pharma's winners and losers  FiercePharma Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter Financial Results for 2022  Bristol-Myers Squibb Bristol Myers Squibb - Bristol Myers Squibb to Report Results for First Quarter 2022 on April 29, 2022  Bristol-Myers Squibb Looking At Bristol-Myers Squibb's Recent Whale Trades  Benzinga Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021  Bristol-Myers Squibb Bristol Myers Squibb - Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers  Bristol-Myers Squibb Bristol Myers Squibb - Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes  Bristol-Myers Squibb Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference  Bristol-Myers Squibb Bristol Myers Squibb Announces Dividend  Bristol-Myers Squibb GentiBio could earn $1.9 billion under IBD deal with BMS  The Pharma Letter Is There More Room For Growth In Bristol Myers Squibb Stock?  Forbes LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York  Bristol-Myers Squibb 2 Top Healthcare Stocks to Buy Right Now  Nasdaq Bristol Myers Squibb - Bristol Myers Squibb to Demonstrate the Strength of its Growing Cardiovascular Portfolio at the American College of Cardiology's 71st Annual Scientific Session  Bristol-Myers Squibb Bristol Myers Squibb to Participate in Upcoming Investor Conferences on March 16  Bristol-Myers Squibb Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug  Reuters Bristol Myers Squibb Stock: Downgrade To Hold Now (NYSE:BMY)  Seeking Alpha 3 Unstoppable Stocks That Don't Care About the Bear Market  The Motley Fool What?s Happening With Bristol Myers Squibb Stock?  Forbes Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript  The Motley Fool Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at Bernstein 38th Annual Strategic Decisions Conference (Transcript)  Seeking Alpha Bristol Myers Squibb - Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S.  Bristol-Myers Squibb Here?s Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether  Forbes Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company  Forbes Bristol Myers Squibb (BMY): Safe Spot For Worrisome Investor  Seeking Alpha Bristol Myers Squibb (NYSE:BMY): Still On Track  Seeking Alpha New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis  Bristol-Myers Squibb Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know  Nasdaq Is A Rise Imminent For Bristol Myers Squibb Stock?  Forbes Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)  Bristol-Myers Squibb Kahn Brothers Portfolio ? Q2 2022 Update  Seeking Alpha 5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy  The Motley Fool New Drugs in Pipeline for Hypertension, the Silent Global Pandemic  PR Newswire UK Bristol-Myers, Novartis win FDA label expansions for cancer medications (NYSE:BMY)  Seeking Alpha 'Major blunder': Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update  FiercePharma Bristol Myers Squibb: A Safe Haven In Times Of Uncertainty  Seeking Alpha Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference  Bristol-Myers Squibb Bristol Myers Squibb: Bull Thesis Supported By Technicals (NYSE:BMY)  Seeking Alpha 3 Unstoppable Dividend Stocks to Buy in August  Nasdaq Bristol Myers Squibb - Bristol Myers Squibb Announces New Prescription Drug User Fee Act Goal Date for Reblozyl® (luspatercept-aamt) Supplemental Biologics License Application  Bristol-Myers Squibb BMY Stock: Bristol Expects $10.5 Billion Shortfall This Year As Generics Loom | Investor's Business Daily  Investor's Business Daily What?s Next For Bristol Myers Squibb Stock After An 11% Fall In A Month?  Forbes Bristol Myers Squibb Stock: Looks Strong In 2022 (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb: Fading The Rally Before Earnings (BMY)  Seeking Alpha Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Forbes Bristol Myers Squibb - Bristol Myers Squibb Presents Interim Results from Long-Term Study Reinforcing Maintenance of Response and Safety Profile of Zeposia (ozanimod) in Patients with Moderately to Severely Active Ulcerative Colitis  Bristol-Myers Squibb Is Bristol-Myers Squibb Company's (NYSE:BMY) 20% ROE Strong Compared To Its Industry?  Simply Wall St Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022  Business Wire Bristol-Myers Squibb Stock Is A Strong Buy On Future Growth Potential (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb - Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma  Bristol-Myers Squibb Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers  Business Wire Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year  InvestorPlace Bristol-Myers Squibb Snags Another Approval for This Mega-Blockbuster Drug  The Motley Fool Ad hoc: Evotec and Bristol Myers Squibb extend and expand strategic partnership  Evotec What To Expect From Bristol Myers Squibb Stock After Q3 Results?  Forbes Bristol Myers Squibb My Choice For Dividend Growth (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb Stock: Bull vs. Bear  The Motley Fool Bristol-Myers Squibb downgraded at Morgan Stanley (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma  Bristol-Myers Squibb Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know  Nasdaq Bristol Myers Squibb to Participate in Bernstein's 38th Annual Strategic Decisions Conference  Business Wire BMY Stock: How A $4.1 Billion Buyout Is Leveraging Its Cancer Regime  Investor's Business Daily Bristol Myers Squibb: It's The Best Time Ever To Buy BMY Stock  Seeking Alpha What's Behind Bristol Myers Squibb's Latest Partnership?  The Motley Fool Bristol Myers Squibb (BMY) Stock: $81 Price Target And Outperform Rating  Pulse 2.0 BBIO stock climbs after agreement with Bristol Myers Squibb (NYSE:BMY)  Seeking Alpha Bristol Myers must face a lawsuit filed by former Celgene shareholders  FiercePharma U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb's Supplemental Biologics License Application for Breyanzi (lisocabtagene maraleucel) as a Second-Line Therapy for Relapsed or Refractory Large B-cell Lympho  Bristol-Myers Squibb Here's A Better Pharmaceutical Pick Over Merck Stock  Forbes Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether  Nasdaq Bristol Myers posts long-term data for heart-disease drug in late-stage trial (NYSE:BMY)  Seeking Alpha Form 8-K 2seventy bio, Inc. For: Aug 10  StreetInsider.com Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference  Business Wire Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb  Evotec UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?  FierceBiotech Bristol Myers Squibb Announces Positive Topline Results from Phase 3 VALOR-HCM Trial, Evaluating Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy Who are Eligible for Septal Reduction Therapy  Bristol-Myers Squibb Bristol Myers Squibb (BMY) Stock: $64 Price Target From Morgan Stanley  Pulse 2.0 Kirkland Represents Bristol-Myers Squibb Company on Offering of $6B of Senior Notes | News  Kirkland & Ellis LLP Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities  Business Wire Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan  FiercePharma Bristol Myers Squibb Stock: Value Time Again (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference  Business Wire Bristol Myers Squibb: Should You Buy the Dip?  The Motley Fool Infinity Pharma stock gains 24% on survival analysis data for a phase 2 trial, Q2 results  Seeking Alpha
For more news about Bristol-Myers Squ click here:
Bristol-Myers Squ News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources